H. Paul Dorman's most recent trade in Phio Pharmaceuticals Corp was a trade of 10,000 Common stock, $0.0001 par value done . Disclosure was reported to the exchange on Feb. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp | H. Paul Dorman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 10,000 | 20,370 (1%) | 0% | 0 | Common stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | H. Paul Dorman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,000 | 10,370 (0%) | 0% | 0 | Common stock, $0.0001 par value |